| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.33 | 1e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |